Skip to main content Back to Top
Advertisement

6/8/2022

Heparin Injection

Products Affected - Description

    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0540-13
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0542-13
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 0.5 mL prefilled syringe, 24 count, NDC 63323-0118-05
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0047-10
    • Heparin Sodium solution for injection, Hikma, 1,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0391-12
    • Heparin Sodium solution for injection, Hikma, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 00641-2450-55
    • Heparin Sodium solution for injection, Hikma, 10,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0410-12
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 0.5 mL preservative-free vial, 10 count, NDC 00641-6204-10
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0400-12
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00641-2460-55
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 30 mL vial, 25 count, NDC 71288-0402-31
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0404-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 4 mL vial, 25 count, NDC 71288-0404-05
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 10 mL vial, 25 count, NDC 71288-0403-11
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00409-2720-01
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00069-0058-01
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 00409-2720-03
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 00069-0059-03
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00069-0059-01
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00409-2723-02
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 25021-0400-10
    • Heparin Sodium solution for injection, Sagent, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 25021-0402-10

Reason for the Shortage

    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Meitheal Pharma did not provide a reason for the shortage.
    • Mylan has heparin injection available.
    • Pfizer has heparin injection on shortage due to increased demand and manufacturing delays.
    • Sagent has heparin injection on shortage due to increased demand and manufacturing delays.

Available Products

    • Heparin Sodium solution for injection, BBraun, 10,000 unit/mL, 0.5 mL prefilled syringe, 10 count, NDC 00264-5705-10
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0540-11
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0540-15
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 2 mL single dose vial, 25 count, NDC 63323-0276-02
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 63323-0540-31
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 0.5 mL preservative-free vial, 25 count, NDC 63323-0543-02
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 0.5 mL preservative-free vial, 25 count, NDC 63323-0543-13
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 63323-0459-09
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0542-07
    • Heparin Sodium solution for injection, Fresenius Kabi, 20,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0915-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 20,000 unit/mL, 1 mL glass multiple dose vial, 25 count, NDC 63323-0915-13
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0262-06
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0108-10
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 1 mL syringe, 10 count, NDC 00641-6199-10
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0402-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 10 mL vial, 25 count, NDC 71288-0402-11
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 10 mL vial, NDC 71288-0402-10
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 30 mL vial, NDC 71288-0402-30
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 units/mL, 2 mL vial, 25 count, NDC 71288-0400-03
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 1 mL vial, NDC 71288-0404-01
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 4 mL vial, NDC 71288-0404-04
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0403-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 10 mL vial, NDC 71288-0403-10
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0372-99
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 67457-0385-99
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 67457-0384-99
    • Heparin Sodium solution for injection, Mylan, 10,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0602-99
    • Heparin Sodium solution for injection, Mylan, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 67457-0603-99
    • Heparin Sodium solution for injection, Mylan, 20,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0373-99
    • Heparin Sodium solution for injection, Mylan, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0374-99
    • Heparin Sodium solution for injection, Mylan, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 67457-0383-99
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00409-2720-02
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 30 mL multiple dose vial, 10 count, NDC 00069-0137-03
    • Heparin Sodium solution for injection, Pfizer, 10,000 unit/mL, 0.5 mL preservative-free Carpuject syringe, 50 count, NDC 00409-1316-32
    • Heparin Sodium solution for injection, Pfizer, 10,000 unit/mL, 1mL single dose vial, 25 count, NDC 00409-2721-01
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1mL Carpuject syringe, 50 count, NDC 00409-1402-12
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1mL single dose vial, 25 count, NDC 00409-2723-01
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0400-01
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 2 mL single dose vial, 25 count, NDC 25021-0401-02
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 25021-0400-30
    • Heparin Sodium solution for injection, Sagent, 10,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0403-01
    • Heparin Sodium solution for injection, Sagent, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 25021-0403-04
    • Heparin Sodium solution for injection, Sagent, 20,000 unit/mL, 1mL multiple dose vial, 25 count, NDC 25021-0404-01
    • Heparin Sodium solution for injection, Sagent, 5,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0402-01

Estimated Resupply Dates

    • Fresenius Kabi has heparin 5,000 unit/mL 10 mL vials on back order and the company estimates a release date in early-June 2022. There are short-dated 1,000 unit/mL 1 mL vials available with an expiration date of < 1 months. There are short-dated 10,000 unit/mL 1 mL vials available with an expiration date of < 2 months. The 5,000 unit/mL 0.5 mL Simplist syringes are on back order and the company estimates a release date of 3rd quarter 2022. The 20,000 unit/mL 1 mL glass vials are available with an expiration date of < 9 months.
    • Hikma has heparin 1,000 unit/mL 2 mL vials on back order and the company estimates a release date of late-May to early-June 2022. The 1,000 unit/mL 30 mL vials and 5,000 unit/mL 10 mL vials are on back order and the company cannot estimate a release date. The 5,000 unit/mL 2 mL vials and 5,000 unit/0.5 mL vials are on allocation. The 10,000 units/mL 2 mL vials are on back order and the company estimates a release date of late-June to early-July 2022.
    • Meitheal Pharma has heparin 1,000 unit/mL 30 mL vials and 5,000 unit/mL 10 mL vials on allocation. The 10,000 unit/mL 1 mL and 4 mL vials are on back order and the company estimates release dates of late-June 2022 for the 1 mL vials and mid-June 2022 for the 4 mL vials.
    • Pfizer has heparin 1,000 unit/mL 10 mL vials available in limited supply. The 5,000 unit/mL 10 mL vials are on back order and the company estimates a release date of September 2022. The 1,000 unit/mL 10 mL vials and 5,000 unit/mL 1 mL and 10 mL vials are on back order and the company estimates release dates in February 2023. The 1,000 unit/mL 30 mL glass vials are on back order and the company estimates a release date in June 2022.
    • Sagent has 5,000 unit/mL 10 mL vials on back order and the company cannot estimate a release date. The 10,000 unit/mL 4 mL vials are on back order and the company estimates a release date of July 2022. The 1,000 unit/mL 10 mL vials and 20,000 unit/mL 1 mL vials are on back order and the company estimates a release date of June 2022.

Updated

Updated June 8, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created October 13, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.